Author:
Cohen Philip L.,Traisak Pamela
Reference46 articles.
1. Barone F, Bombardieri M, Manzo A, Blades MC, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren’s syndrome. Arthritis Rheum. 2005;52:1773–184.
2. Fox RI, Adamson TC 3rd, Fong S, Young C, Howell FV. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjögren syndrome. Diagn Immunol. 1983;1:233–9.
3. Soliotis FC, Moutsopoulos HM. Sjögren’s syndrome. Autoimmunity 2004;37:305–7.
4. Manganelli P, Fietta P. Apoptosis and Sjögren syndrome. Semin Arthritis Rheum. 2003;33:49–65.
5. Steinfeld SD, Demols P, Salmon I, Kiss R, Appelboom T. Infliximab in patients with primary Sjögren’s syndrome: a pilot study. Arthritis Rheum. 2001;44:2371–5.